KF
GNOM icon

Krilogy Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Krilogy Financial’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,738
Closed -$922K – 231
2024
Q4 		$922K Sell
23,738
-3,892
-14% -$164K 0.06% 169
2024
Q3 		$1.24M Buy
+27,630
New +$1.24M 0.09% 151

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Krilogy Financial's GNOM Position: Q1 2025 in Review

Krilogy Financial sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2025, closing a stake of 23,738 shares — an estimated $922K sold.

Krilogy Financial first reported a position in GNOM in Q3 2024 and held it in 2 quarters. The position peaked at $1.24M in Q3 2024. 58 funds tracked by Wall St. Rank hold GNOM as of Q1 2025.

  • Krilogy Financial reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Krilogy Financial sold 23,738 Global X Genomics & Biotechnology ETF shares in Q1 2025, an estimated $922K.
  • Krilogy Financial first reported a position in Global X Genomics & Biotechnology ETF in Q3 2024 and held it in 2 quarters.
  • Krilogy Financial's Global X Genomics & Biotechnology ETF position peaked at $1.24M in Q3 2024.
  • 58 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2025.

Based on Krilogy Financial's 13F filing for Q1 2025, filed 16 Apr 2025.